TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Daily Dose of Medication (DDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Planned temperature achieved at target area of sonication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety measured by GAD7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety measured by GAD2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in body fat percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental recovery (IR) (plasma FIX activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized spontaneous bleeding rate (AsBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who develop an inhibitor to FIX
Endpoint domain: Adverse events/effects
Primary endpoint: Social anxiety: avoidance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social anxiety: severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Agoraphobia: avoidance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Agoraphobia: severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Multiple measures for change in levels of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of PWH prescribed 3HP (or IPT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Apparent Diffusion Coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to glucagon treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes Self-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes Self-Management Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-Exercise Recovery
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: IPAQ score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Net Clinical Adverse Clinical Events (NACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of a bone crack and/or fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to first occurrence of cardiovascular death and worsening of heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of Hypothyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of sampling failures
Endpoint domain: Adverse events/effects
Primary endpoint: physical functional performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the incidence of sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute procedure success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammatory and retentionnal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: product tolerance
Endpoint domain: Adverse events/effects
Primary endpoint: ROM lost during the trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HO appearance on CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blastocyst outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GABA Blood Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Increased joint functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in the quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bony Union
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Medication Compliance Reporting Scale change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COPD and Asthma Fatigue Scale (DAS) change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Asthma Control Test (AKT) change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ability to use inhalation devices change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of body composition (weight, kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Node Recurrence Rate
Endpoint domain: Mortality/survival
Primary endpoint: Biochemical parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vBMD at the Distal Femur after 12 months of romosozumab treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and joint outcomes
Primary endpoint: Change in vBMD at the distal femur after an additional 12 months of denosumab treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and joint outcomes
Primary endpoint: Achieving ACPICR standards for physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of good functional outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Replicative stress in hair follicle stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scores on the physical function scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Scores on the pain symptom scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Detection of proctosigmoiditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean Corneal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact Lens Impact on Quality of Life (CLIQ) questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients dead
Endpoint domain: Mortality/survival
Primary endpoint: mean tumor-to-background ratio (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of adequate tumor resection margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Acute Subjective Response to Cannabis Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of major adverse events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Strength of the upper-limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Willingness to Pay for CBT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Gambling Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Well-Being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Home Blood Pressure Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient loss of chance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported relief of menopausal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient reported sexual function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average number of patients recruited per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Parenting Stress Index Short Form (PSI) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Child Behavior Checklist (CBCL)-Preschool form total problems scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients appropriately prescribed OACs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Numeric Rating Scale of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in volume of fat from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NT-pro-BNP or BNP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: thalamo-sensory-cortex connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Absolute OFF-time from baseline to end of study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with one hour or more reduction in Absolute OFF-time from baseline to end of study (OFF-time responders)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Absolute ON-time from baseline to end of study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood pressure measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood pressure measurement stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline level of humoral immunity at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline level of cellular immunity at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Grade of tendon bone healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft maturity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular myocardial performance index (MPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median PROM-ED scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adherence of diabetic patients to periodontal care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fetal growth measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Guideline compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Corneal nerve fibre density (CNFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Scar Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of Scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Ashworth Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Diarrhea among household members
Endpoint domain: Adverse events/effects
Primary endpoint: spinal curvature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Infant self-regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental knowledge of child development
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal parenting behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Universal Parkinson Disease Rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of participants with moderate to severe GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity and specificity of TEE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in disability score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Standards of Neurological Classification of SCI (ISNCSCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP) Version 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: TRI hand function test (TRI-HFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tactile Discrimination Test (TDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnosis of migraine using EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: DSM-5 diagnosis of substance use disorder
Endpoint domain: Adverse events/effects
Primary endpoint: Superimposition accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burke Fahn Marsden's Dystonia Rating Scales (BFMDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Solicited Local and Systemic Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory Culture Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participant acceptance and adherence to program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant satisfaction and usability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Practicality of participant self-monitoring behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in resting-state functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Static fracture migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in dACC GSH Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of biliary acute pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Italian Central Sensitization Inventory (CSI-I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative sensory testing (QST) - Tactile discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative sensory testing (QST) - Mechanical allodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain spatial summation to assess the pain descending inhibitory system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDNF Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of All Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of All Grade 3 Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of All Grade 3 Laboratory Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Cardiac QT Interval (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Oriented Composite Endpoint (POCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the Ultrasonographic Nomogram in Predicting Breast Lesion Malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recurrence of VVS
Endpoint domain: Mortality/survival
Primary endpoint: Time to first syncopal episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in NSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Reported Outcome Measures Information System-29 (PROMIS-29)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain and Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of Cognitive Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of Postoperative Recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative shivering grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease progression (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of difficult mask ventilation and intubation
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of different fungal species in positive fungal cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Absence of radiological disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Good on time (GOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Imaging safety outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of neuroendocrine tumor lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Effective conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leukocytosis in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: C-reactive protein (CRP) levels in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-1 levels in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-6 levels in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-10 levels in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF-alpha levels in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Flow cytometry count of leukocytes, stromal cells and endothelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Microbiological sterility of nanofat autografts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Glycerol rate of appearance normalized to fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Palmitate rate of appearance normalized to fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum levels of indoxyl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum levels of p-Cresyl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum levels of trimethylamine N-Oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in brain amyloid deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Kellgren Lawrence scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Western Ontario and Mc Master Universities osteoarthritis Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dialysis Treatment Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of likely pathogenic structural variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients for whom a genotype-phenotype correlation is found
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintaining tailored treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in moderate to severe depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Knee Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Good Functional Outcome of Modified Rankin Score 0-2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maximum urethral closure pressure (MUCP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure and Vascular Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Rate (HR) and HR variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CR/CRi rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Fear of Cancer Recurrence Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in POTSapp Usability as measured by uMARS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in POTSapp Usage - number of page views
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in POTSapp Usage - time spent in app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference in oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes